Ron M. C. Herings

11.5k citations

247 papers · 8.4k indexed · h-index 47

Family Practice top 0.5%
Toxicology top 0.1%
- Pharmacovigilance and Adverse Drug Reactions 22
Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes 18
Orthopedics and Sports Medicine top 0.5%
Gastroenterology top 1%
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 26
- Pharmaceutical Economics and Policy 16
Endocrinology, Diabetes and Metabolism
- Diabetes Treatment and Management 25
- Diabetes Management and Research 17
Pharmacology
- Inflammatory mediators and NSAID effects 20
Surgery
- Lipoproteins and Cardiovascular Health 19

Co-authors: Joëlle A. Erkens Fernie J. A. Penning‐van Beest Bruno H. Stricker Wim Goettsch Miriam Sturkenboom Myrthe P. P. van Herk‐Sukel Nancy S. Breekveldt‐Postma Hubert G. M. Leufkens
Cited by: Family Practice Toxicology Geriatrics and Gerontology
Journals: The Lancet (1 paper)SHILAP Revista de lepidopterología (1 paper)Annals of Internal Medicine (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Ron M. C. Herings

240 papers receiving 8.0k citations

Peers

Countries citing papers authored by Ron M. C. Herings

Since Specialization

Citations

This map shows the geographic impact of Ron M. C. Herings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron M. C. Herings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron M. C. Herings more than expected).

Fields of papers citing papers by Ron M. C. Herings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron M. C. Herings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron M. C. Herings. The network helps show where Ron M. C. Herings may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ron M. C. Herings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ron M. C. Herings Line = papers co-authored together Ron M. C. Herings links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderly Family Practice ·Charlotte Andriessen,Marieke T. Blom,Beryl A. C. E. van Hoek,Anna W de Boer,Petra Denig,Ron M. C. Herings,Angela de Rooij-Peek,Rob J. van Marum,Jacqueline G. Hugtenburg,Daniël H. van Raalte,Liselotte van Bloemendaal,Giel Nijpels,Marjan J. Westerman,Rimke C. Vos,Petra J. M. Elders	2025	0
2	Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020 Diabetes Metabolic Syndrome and Obesity ·Jetty A. Overbeek,Giel Nijpels,Karin M. A. Swart,Marieke T. Blom,Petra J. M. Elders,Ron M. C. Herings	2024	6
3	Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics Frontiers in Pharmacology ·Linda C. Hendriksen,M. S. Mouissie,Ron M. C. Herings,Paul D. van der Linden,Loes E. Visser	2024	1
4	Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands Drugs - Real World Outcomes ·Annemarie Voss,Elisabeth Smits,Karin M. A. Swart,Yanina Balabanova,Gunnar Brobert,Kiliana Suzart‐Woischnik,Ron M. C. Herings,Tania Schink,Ulrike Haug	2023	1
5	Women on diuretics have a higher risk of hospital admission because of hyponatremia than men Pharmacoepidemiology and Drug Safety ·Linda C. Hendriksen,Paul D. van der Linden,Ron M. C. Herings,Bruno H. Stricker,Loes E. Visser	2023	7
6	Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands: a cohort study BMJ Open ·Aarent R.T. Brand,Eline Houben,Irene D. Bezemer,Frank L.J. Visseren,Michiel L. Bots,Ron M. C. Herings,Gert‐Jan de Borst	2021	4
7	Development and validation of an algorithm to estimate the risk of severe complications of COVID-19: a retrospective cohort study in primary care in the Netherlands BMJ Open ·Ron M. C. Herings,Karin M. A. Swart,B A van der Zeijst,Amber A. van der Heijden,Koos van der Velden,Eric Hiddink,Martijn W. Heymans,(unknown),(unknown),Hein van Hout,Joline W. J. Beulens,Giel Nijpels,Petra J. M. Elders	2021	2
8	Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice Expert Opinion on Drug Safety ·Luis A. Garcı́a Rodrı́guez,Mari‐Ann Wallander,Leif Friberg,Ana Ruigómez,Tania Schink,Irene D. Bezemer,Ron M. C. Herings,Saad Shakir,Alison Evans,Miranda Davies,Kiliana Suzart‐Woischnik,Pareen Vora,Yanina Balabanova,Montse Soriano‐Gabarró,Gunnar Brobert	2020	4
9	Cohort profile: the PHARMO Perinatal Research Network (PPRN) in the Netherlands: a population-based mother–child linked cohort BMJ Open ·Eline Houben,Lisa Broeders,Eric A.P. Steegers,Ron M. C. Herings	2020	6
10	Impact of a Forced Dose-Equivalent Levothyroxine Brand Switch on Plasma Thyrotropin: A Cohort Study Thyroid ·Linda E. Flinterman,Josephina G. Kuiper,Joke C. Korevaar,Liset van Dijk,Karin Hek,Eline Houben,Ron M. C. Herings,Anton Franken,Johan P. de Graaf,Annemieke Horikx,Marijke Janssens,Rietje Meijer,A Wijbenga,Eugène van Puijenbroek,Bruce H. R. Wolffenbuttel,Thera P. Links,Peter H. Bisschop,Eric Fliers	2020	17
11	[Prevalence of diabetes mellitus in the Netherlands more than doubled in the period 1999-2014]. PubMed ·Jetty A. Overbeek,A W A van der Heijden,Ron M. C. Herings,Giel Nijpels	2018	5
12	Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project PLoS ONE ·Gwen Masclee,Huub Straatman,Andrea Arfè,Jordi Castellsagué,Edeltraut Garbe,Ron M. C. Herings,Bianca Kollhorst,S Lucchi,Susana Perez‐Gutthann,Silvana Romio,R Schade,Tania Schink,Martijn J. Schuemie,Lorenza Scotti,Cristina Varas‐Lorenzo,Vera E. Valkhoff,Marco Villa,Miriam Sturkenboom	2018	44
13	DB1 - GLYCAEMIC CONTROL, CARDIOVASCULAR DISEASE AND MORTALITY IN TYPE 2 DIABETES (T2D) PATIENTS IN A REAL LIFE SETTING OVER TIME: POPULATION-BASED DATA FROM THE NETHERLANDS Value in Health ·Eline Houben,Edith M. Heintjes,S. Cremers,W. Beekman,Penning-van Beest F,Coen D.A. Stehouwer,Ron M. C. Herings	2018	0
14	Risk of Fracture with Thiazolidinediones: An Individual Patient Data Meta-Analysis Pharmacoepidemiology and Drug Safety ·Marloes T. Bazelier,Frank de Vries,Peter Vestergaard,Ron M. C. Herings,Arlene M. Gallagher,Hubert G. M. Leufkens,Tjeerd van Staa	2013	8
15	Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues? BMC Pediatrics ·Vera E. Valkhoff,R Schade,Geert W. ‘t Jong,Silvana Romio,Martijn J. Schuemie,Andrea Arfè,Edeltraut Garbe,Ron M. C. Herings,S Lucchi,Gino Picelli,Tania Schink,Huub Straatman,Marco Villa,Ernst J. Kuipers,Miriam Sturkenboom	2013	29
16	Use of Aspirin postdiagnosis improves survival for colon cancer patients British Journal of Cancer ·Esther Bastiaannet,Katia Sampieri,Olaf M. Dekkers,A.J.M. de Craen,Myrthe P. P. van Herk‐Sukel,V.E.P.P. Lemmens,C.B.M. van den Broek,J.W.W. Coebergh,Ron M. C. Herings,Cornelis J.�H. van de Velde,Riccardo Fodde,Gerrit‐Jan Liefers	2012	132
17	PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus: Evidence from a Dutch Cohort Value in Health ·Edith M. Heintjes,Fernie J. A. Penning‐van Beest,Shreekant Parasuraman,Susan Grandy,Michael Pollack,Ron M. C. Herings	2011	4
18	Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study; Current Medical Research and Opinion ·Wim Goettsch,Donald Yin,E. Alemao,Olaf H. Klungel,Anton F. H. Stalenhoef,Ron M. C. Herings	2004	27
19	Increased suicide attempt rate among patients interrupting use of atypical antipsychotics Pharmacoepidemiology and Drug Safety ·Ron M. C. Herings,Joëlle A. Erkens	2003	92
20	Farmacomorbiditeitskoppeling in een Nederlands ziekenhuis: Nieuwe mogelijkheden voor farmaco-epidemiologisch onderzoek Pure Amsterdam UMC ·P. A. M. M. Boermans,(unknown),B. H. Graatsma,Ron M. C. Herings	2002	1

About Ron M. C. Herings

Ron M. C. Herings is a scholar working on Toxicology, Family Practice and Geriatrics and Gerontology, having authored 247 papers that have together received 8.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (26 papers), Diabetes Treatment and Management (25 papers), Pharmacovigilance and Adverse Drug Reactions (22 papers), Inflammatory mediators and NSAID effects (20 papers), Lipoproteins and Cardiovascular Health (19 papers), Pharmaceutical Practices and Patient Outcomes (18 papers), Diabetes Management and Research (17 papers) and Pharmaceutical Economics and Policy (16 papers). The work is most often cited by research in Family Practice (426 citations), Toxicology (569 citations) and Geriatrics and Gerontology (579 citations). Ron M. C. Herings has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Joëlle A. Erkens, Fernie J. A. Penning‐van Beest, Bruno H. Stricker, Wim Goettsch, Miriam Sturkenboom, Myrthe P. P. van Herk‐Sukel, Nancy S. Breekveldt‐Postma, Hubert G. M. Leufkens, J.W.W. Coebergh and Anthonius de Boer. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact